Effect of sleep disturbance on disease outcome in inflammatory bowel disease patients with clinical remission: a prospective cohort study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20230321008

Enrollment

Registered

2023-03-21

Start date

2022-10-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Disease flare up in inflammatory bowel disease patients with or without sleep disturbance Inflammatory bowel disease, Sleep, polysomnography, Clinical outcome

Interventions

Inflammatory bowel disease patients with PSQI score more than 5,Inflammatory bowel disease patients with PSQI score less than or equal to 5

Other,Other

Sleep disturbance,No sleep disturbance

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: IBD patients with clinical remission (no drug adjustment for more than 2 months and use steroids less than or equal to 10 mg per day)

Exclusion criteria

Exclusion criteria: 1. Pregnancy or Lactating 2. Patient with stoma 3. Shift workers 4. Active cancer 5. Obstructive sleep apnea syndrome that required continuous positive airway pressure, obstructive sleep apnea syndrome with apnea-hypopnea index more than 30 episodes per hour

Design outcomes

Primary

Measure	Time frame
Disease flare up within 6 months Score (CDAI, pMayo score), Hospitalization/Surgery related to IBD	—

Secondary

Measure	Time frame
Disease flare up within 12 months Score (CDAI, pMayo score), Hospitalization/Surgery related to IBD	—

Countries

Thailand

Contacts

Public ContactKanteera Sriyudthsak

King Chulalongkorn Memorial Hospital

unkanteera@gmail.com0816226896

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026